Posted by Michael Wonder on 16 Jan 2020
Pharma execs pitch ideas at JPM20 to lower drug costs. None of them include dropping their own prices.
16 January 2020 - CEOs from the world’s largest pharmaceutical companies pitched ideas for lowering drug prices at the J.P. Morgan Healthcare Conference in San Francisco this week.
None, however, offered to cut prices on any of their own drugs.
Some of the executives, like Regeneron CEO Leonard Schleifer, suggested making changes to Medicare, the federal government’s health insurance plan for the elderly, by adding an out-of-pocket maximum for beneficiaries. Others, including Pfizer CEO Albert Bourla, supported passing rebates paid to pharmacy benefit managers through to consumers, arguing the current system drove up list prices and out-of-pocket costs.
